Global Extracorporeal Membrane Oxygenation System Market Size By Type (Veno-Arterial (VA), Veno-Venous (VV)), By Application (Newborn, Children), By Region, And Segment Forecasts, 2023 to 2032

The Global Extracorporeal Membrane Oxygenation (ECMO) System Market was valued at USD 700 million in 2023 and is projected to reach USD 1.45 billion by 2031, growing at a CAGR of 9.3% during the forecast period from 2023 to 2031. This growth is primarily attributed to the rising incidence of respiratory and cardiac failure, increasing adoption of ECMO in critical care units, and technological advancements in ECMO systems. ECMO plays a vital role in providing prolonged cardiac and respiratory support to patients whose heart and lungs are unable to sustain life, particularly in cases of severe ARDS, cardiac arrest, or during complex surgical procedures.

Drivers:

1. Rising Prevalence of Cardiopulmonary Diseases:

The global surge in chronic respiratory and cardiovascular conditions, such as COPD, heart failure, and ARDS, is significantly boosting the demand for ECMO systems.

2. Technological Advancements:

Innovations in portable ECMO systems, integration of AI for monitoring, and user-friendly interfaces are making ECMO more efficient and easier to operate in intensive care settings.

3. Increasing Number of ECMO Centers:

A growing number of hospitals and specialized critical care units are adopting ECMO systems as part of their life-saving interventions, especially in developed regions.

Restraints:

1. High Cost and Maintenance Requirements:

The high initial cost of ECMO systems, along with the requirement for continuous maintenance and monitoring, can limit adoption, especially in developing economies.

2. Risk of Complications:

ECMO procedures involve significant risks such as bleeding, infections, and mechanical failures, which can deter its widespread use in general clinical settings.

Opportunity:

1. Expansion in Emerging Markets:

Countries in Asia-Pacific and Latin America are seeing improved healthcare infrastructure and increased healthcare spending, offering new avenues for ECMO adoption.

2. Increased Use in Neonatal and Pediatric Care:

The growing acceptance of ECMO for neonates and pediatric patients suffering from congenital heart diseases or respiratory failure presents new market opportunities.

Market by System Type Insights:

Based on system type, the Venovenous (VV) ECMO segment dominated the market in 2023, due to its widespread use in cases of severe respiratory failure such as ARDS. VV ECMO is preferred for lung support without affecting heart function, making it the first-line intervention in numerous ICU setups. However, Venoarterial (VA) ECMO is expected to witness strong growth during the forecast period due to its utility in cardiac failure and post-cardiotomy support.

Market by End-use Insights:

In terms of end-use, the Hospital segment accounted for the largest share in 2023, contributing over 65% of the global revenue. The increasing number of ECMO procedures conducted in intensive care units, cardiac centers, and post-operative recovery wards has reinforced this dominance. Additionally, the Ambulatory Surgical Centers (ASCs) segment is gaining traction due to the rising focus on portable ECMO and early patient mobility protocols.

Market by Regional Insights:

North America led the global ECMO system market in 2023, attributed to the presence of advanced healthcare infrastructure, higher awareness of ECMO procedures, and favorable reimbursement policies in the U.S. and Canada. Asia-Pacific is projected to register the highest CAGR during the forecast period, driven by increasing investments in healthcare infrastructure and growing prevalence of respiratory diseases in countries like China, India, and South Korea.

Competitive Scenario:

Prominent players in the global ECMO system market include Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, MicroPort Scientific Corporation, Abbott Laboratories, Fresenius Medical Care AG & Co. KGaA, Nipro Corporation, Xenios AG, and Eurosets Srl. These companies are focusing on product innovation, strategic partnerships, and global expansion.

Key Developments:

2023: Medtronic launched a compact ECMO unit equipped with AI-enhanced monitoring to reduce complications in ICU settings.

2024: Getinge AB partnered with a leading hospital network in Asia to deploy mobile ECMO units across emergency care units.

2025: LivaNova received regulatory approval for its next-gen oxygenator technology aimed at extending ECMO duration with minimal blood trauma.

Scope of Work – Global Extracorporeal Membrane Oxygenation (ECMO) System Market

Report Metric Details

Market Size (2023) USD 700 million

Projected Market Size (2031) USD 1.45 billion

CAGR (2023–2031) 9.3%

Market Segments By System Type (VV ECMO, VA ECMO), End-use (Hospitals, ASCs)

Growth Drivers Rising incidence of cardiopulmonary diseases, ECMO center expansion

Opportunities Pediatric ECMO demand, Emerging markets in APAC and LATAM

Key Market Developments:

April 2023: Terumo launched an advanced hybrid ECMO solution combining membrane oxygenation and renal support in one integrated system.

June 2024: Fresenius announced R&D investment in next-gen wearable ECMO devices for pre-hospital emergency settings.

January 2025: Xenios AG introduced a low-flow ECMO system optimized for neonatal and pediatric patients.

FAQs:

1. What is the current market size of the Global Extracorporeal Membrane Oxygenation System Market?

The market was valued at USD 700 million in 2023.

2. What is the major growth driver of the Global Extracorporeal Membrane Oxygenation System Market?

The primary driver is the increasing prevalence of cardiopulmonary diseases and the growing adoption of ECMO in critical care units.

3. Which is the largest region during the forecast period in the Global Extracorporeal Membrane Oxygenation System Market?

North America held the largest market share in 2023 and is expected to remain dominant throughout the forecast period.

4. Which segment accounted for the largest market share in the Global Extracorporeal Membrane Oxygenation System Market?

The Venovenous (VV) ECMO segment accounted for the largest share in 2023.

5. Who are the key market players in the Global Extracorporeal Membrane Oxygenation System Market?

Key players include Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, and Xenios AG.